Romiplostim for the treatment of chronic immune thrombocytopenia

Technology appraisal guidance
Reference number: TA221
Published: 27 April 2011
Last updated: 26 October 2018

Thrombocytopenic purpura - romiplostim: response to consultee, commentator and public comments on the appraisal consultation document (ACD) 2

Thrombocytopenic purpura - romiplostim: response to consultee, commentator and public comments on the appraisal consultation document (ACD) 2

Thrombocytopenic purpura - romiplostim: response to consultee, commentator and public comments on the appraisal consultation document (ACD) 2
17 June 2012
(246.74 Kb 11 sec)

Adobe Acrobat reader required.

Adobe Acrobat reader required.

This page was last updated: 15 March 2011